Nov 30, 2023 8:00am EST CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024
Nov 28, 2023 8:00am EST bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post
Nov 15, 2023 8:00am EST bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening
Nov 14, 2023 4:01pm EST bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update
Nov 06, 2023 8:00am EST bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales
Oct 10, 2023 8:00am EDT bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conference
Sep 19, 2023 8:00am EDT bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services
Sep 07, 2023 8:00am EDT bioAffinity Technologies to Participate in the H.C. Wainwright Global Investment Conference
Aug 14, 2023 5:03pm EDT bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update
Jul 12, 2023 8:00am EDT AMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung Cancer
